The mouse macrophage-derived apoptosis inhibitor of macrophage (AIM), which is incorporated into adipocytes and induces lipolysis by suppressing fatty acid synthase (FAS) activity, possesses three potential N-glycosylation sites. Inactivation of N-glycosylation sites revealed that mouse AIM contains two N-glycans in the first and second scavenger receptor cysteine-rich domains, and that depletion of N-glycans decreased AIM secretion from producing cells. Interestingly, the lack of N-glycans increased AIM lipolytic activity through enhancing AIM incorporation into adipocytes. Although human AIM contains no N-glycan, attachment of N-glycans increased AIM secretion. Thus, the N-glycosylation plays important roles in the secretion and lipolytic function of AIM. Structured summary of protein interactions: AIM physically interacts with FAS by anti tag coimmunoprecipitation (View interaction).
- Apoptosis inhibitor of macrophage (AIM)
- Fatty acid synthase (FAS)
- Lipid droplet coating protein
ASJC Scopus subject areas
- Structural Biology
- Molecular Biology
- Cell Biology